[ Inside the business ]

ADM stock analysis

ADM · Archer-Daniels-Midland Co

Fats and oils. Growing 10%.

Nothing unusual in its latest filings.

The future, in 7 questions

01 What's priced in?Not available

Needs today's sales, share count and price.

02 Is the wave rising?Biomanufacturing · 0.8×
'20'21'22'23'24'2535
#10 of 20 mentioning it
03 Will customers keep buying?Sales +10%, speeding up
No customer over 10%
Prepaid $159MSales +10%, speeding up
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Not enough data
Before running costs: 7% → 6%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares −5.5%/yrDebt $8.7B
07 What could break it?1 to watch
  • Moves strongly with the S&P 500

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth speeding up.

Sales growth +2%, +7%, then +10% vs. a year ago.

What could go wrong

Red flags.

It has moved 0.8× the market. In the 2008 crisis it fell 24% while the market fell 51%. Debt is moderate. 2 red flags in its filings.

Speculative check

Not classified.

Not Self-funding because of: debt over 4× operating profit.

What they sell

Not broken out.

The filings don't split revenue by product in structured data.

Where each dollar goes

Not available.

Cost lines aren't reported in a comparable form.

Its market

0.6× the economy.

The government expects its industry, grain and oilseed milling, to grow 1.2% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Maturity.

It earns cash, still invests, and pays back more than it borrows.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators. Cash covers 59¢ of each $1 of profit.

Competitive advantage

Not measurable.

Returns on capital can't be computed from its filings (common for banks and insurers).

Future bets

$17.9B committed.

Promised to suppliers, per its latest 10-Q. Plus $246M a year on research (0% of sales).

All figures from Archer-Daniels-Midland Co's SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.